1-20 of 118
Krimo Bouabdallah
Close
Sort by
Journal Articles

Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients

Clinical Trials & Observations
Clémentine Sarkozy, Mary Bridgid Callanan, Catherine Thieblemont, Lucie Obéric, Barbara Burroni, Krimo Bouabdallah, Ghandi Damaj, Benoit Tessoulin, Vincent Ribrag, Roch Houot, Franck Morschhauser, Samuel Griolet, Clémentine Joubert, Victoria Cacheux, Vincent Delwail, Violaine Safar, Remy Gressin, Morgane Cheminant, Marie-Helene Delfau-Larue, Olivier Hermine, Elizabeth A. Macintyre, Steven Le Gouill
Journal: Blood
Blood blood.2024023944.
https://doi.org/10.1182/blood.2024023944
Published: 2024
Includes: Supplemental data
Journal Articles

Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma

Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, clémentine Sarkozy, José María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Franck Morschhauser, Houot Roch
Journal: Blood
Blood blood.2024024526.
https://doi.org/10.1182/blood.2024024526
Published: 2024
Includes: Supplemental data
Journal Articles

Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials

Clementine Sarkozy, Mary Callanan, Catherine Thieblemont, Lucie Oberic, Barbara Burroni, Krimo Bouabdallah, Gandhi Laurent Damaj, Benoit Tessoulin, Vincent Ribrag, Roch Houot, Franck Morschhauser, Victoria Cacheux, Vincent Delwail, Violaine Safar, Remy Gressin, Morgane Cheminant, Olivier Hermine, Elizabeth A. Macintyre, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 980.
https://doi.org/10.1182/blood-2023-174416
Published: 2023
Journal Articles

Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma

Gloria Iacoboni, Gilles Crochet, Audrey Couturier, Emmanuel Bachy, Josu Iraola, Thomas Gastinne, Charles Herbaux, Tom Fradon, Mi Kwon, Romain Gounot, Nuria Martinez-Cibrian, Cristina Castilla-Llorente, Manuel Guerreiro, Clementine Sarkozy, Jose Aspa-Cilleruelo, Vincent Camus, Stephanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Pere Barba, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 228.
https://doi.org/10.1182/blood-2023-185035
Published: 2023
Journal Articles

Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries

Herve Ghesquieres, Krimo Bouabdallah, Marc Andre, Philippe Quittet, Cecile Borel, Aspasia Stamatoulas Bastard, Michael Gilbertson, Fabien Le Bras, Catherine Thieblemont, Baptiste Delapierre, Mohamed Touati, Pierre Feugier, Julien Lazarovici, Nadine Morineau, Thomas Gastinne, Isabelle Chaillol, Rod Ramchandren, Harsh Shah, Dipenkumar Modi, Heather Allewelt, Pierre Fustier, Jianfeng Xu, Amit Agarwal, Franck Morschhauser, Cedric Rossi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1717.
https://doi.org/10.1182/blood-2023-188545
Published: 2023
Journal Articles

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Clinical Trials & Observations Brief Report
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, A. Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Journal: Blood
Blood (2023) 142 (2): 141–145.
https://doi.org/10.1182/blood.2022019340
Published: 2023
Journal Articles

Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib

Pier Luigi Zinzani, Muhit Özcan, Marcelo Capra, Armando Santoro, Panayiotis Panayiotidis, Krimo Bouabdallah, Wojciech Jurczak, Charles Phelps, Florian JR Hiemeyer, Lidia Mongay Soler, Jose Garcia-Vargas, Barrett H. Childs, Georg Lenz, Matthew J. Matasar, Martin Dreyling
Journal: Blood
Blood (2022) 140 (Supplement 1): 6470–6473.
https://doi.org/10.1182/blood-2022-167368
Published: 2022
Journal Articles

The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study

David Sibon, Laurence Lamant, Véronique Vergé, Loic Ysebaert, Catherine Thieblemont, Krimo Bouabdallah, Jehan Dupuis, Rémy Gressin, Emmanuel Bachy, Yann Guillermin, Nicolas Daguindau, Charlotte Syrykh, Choquet Sylvain, Pierre Feugier, Caroline Delette, Olivier Casasnovas, Marlene Ochmann, Ronan Le Calloch, Emmanuel Gyan, Herve Tilly, Gandhi Laurent Damaj, Olivier Tournilhac
Journal: Blood
Blood (2022) 140 (Supplement 1): 3680–3682.
https://doi.org/10.1182/blood-2022-170841
Published: 2022
Journal Articles

Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study

Catherine Thieblemont, Javier Munoz, Alessandra Tucci, Carlo Visco, Guillaume Cartron, Paolo Corradini, Ian W. Flinn, Thomas Gastinne, Kamal Krimo Bouabdallah,, Luca Arcaini, Grzegorz S. Nowakowski, Louise Roulin, Max Topp, Shekeab Jauhari, Vladan Vucinic, Peter Martin, Argyrios Gkasiamis, James Drew, Parth Rao, Mark Kaplan, Yiming Cheng, Ju Li, Franck Morschhauser
Journal: Blood
Blood (2022) 140 (Supplement 1): 569–572.
https://doi.org/10.1182/blood-2022-162559
Published: 2022
Journal Articles

CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry

Gilles Crochet, Couturier Audrey, Emmanuel Bachy, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Romain Gounot, Cristina Castilla-LLorente, Clementine Sarkozy, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 4639–4641.
https://doi.org/10.1182/blood-2022-162594
Published: 2022
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, Solene Lecolant, Maya Hacini, Krimo Bouabdallah, Sebastien Bailly, Kamel Laribi, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Pierre Feugier, Anne Banos, Thierry Lamy, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Nicole Straetmans, Richard Delarue, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence De Leval, Gandhi Laurent Damaj
Journal: Blood
Blood (2022) 140 (Supplement 1): 2302–2305.
https://doi.org/10.1182/blood-2022-165217
Published: 2022
Journal Articles

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Clinical Trials & Observations
Emmanuel Bachy, Roch Houot, Pierre Feugier, Krimo Bouabdallah, Reda Bouabdallah, Emmanuelle Nicolas Virelizier, Marie Maerevoet, Christophe Fruchart, Sylvia Snauwaert, Steven Le Gouill, Jean-Pierre Marolleau, Lysiane Molina, Cécile Moluçon-Chabrot, Catherine Thieblemont, Hervé Tilly, Fontanet Bijou, Corinne Haioun, Eric Van den Neste, Bettina Fabiani, Michel Meignan, Guillaume Cartron, Gilles Salles, Olivier Casasnovas, Franck Morschhauser
Journal: Blood
Blood (2022) 139 (15): 2338–2346.
https://doi.org/10.1182/blood.2021013526
Published: 2022
Includes: Supplemental data
Journal Articles

Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study

Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, Stéphanie Guidez, Lysiane Molina, Franck Morschhauser, Anne-Claire Gac, Thomas Gastinne, Kamel Laribi, Vincent Launay, Bohrane Slama, Nawel Belmecheri, René-Olivier Casasnovas, Anne Corby, Eric Durot, Pierre Feugier, Emmanuelle Nicolas-Virelizier, David Sibon, Alina Berriolo-Riedinger, Veronique Edeline, Thierry Vander Borght, Diane Damotte, Alexandra Traverse-Glehen, Marc Andre, Vincent Ribrag
Journal: Blood
Blood (2021) 138 (Supplement 1): 232.
https://doi.org/10.1182/blood-2021-147863
Published: 2021
Journal Articles

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Journal: Blood
Blood (2021) 138 (Supplement 1): 306.
https://doi.org/10.1182/blood-2021-148082
Published: 2021
Journal Articles

A Phase 1/2, Open-Label, Multicenter Study of Isatuximab in Combination with Cemiplimab in Patients with Lymphoma

Carmelo Carlo-Stella, Pier Luigi Luigi Zinzani, Anna Sureda, Luís Francisco Araújo, Olivier Casasnovas, Cecilia Carpio, Su-Peng Yeh, Krimo Bouabdallah, Guillaume Cartron, Won Seog Kim, Raul Cordoba, Youngil Koh, Alessandro Re, Daniela Alves, Martine E.D Chamuleau, Steven Le Gouill, Armando Lopez-Guillermo, Maria Ilidia Moreira, Marjolein W.M. Van Der Poel, Giovanni Abbadessa, Robin Meng, Ran Ji, Lucie Lepine, Rao Saleem, Vincent Ribrag
Journal: Blood
Blood (2021) 138 (Supplement 1): 4362.
https://doi.org/10.1182/blood-2021-148431
Published: 2021
Journal Articles

Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study

Krimo Bouabdallah, Raphaëlle Aubrais, Loïc Chartier, Charles Herbaux, Anne Banos, Pauline Brice, Marlene Ochmann, David Sibon, Jean Marc Schiano De Colella, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Marwa Hammami, Eric Durot, Christophe Bonnet, Margot Robles, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie Parrens, Noel-Jean Milpied, Gandhi Laurent Damaj
Journal: Blood
Blood (2021) 138 (Supplement 1): 620.
https://doi.org/10.1182/blood-2021-150953
Published: 2021
Journal Articles

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Charles Herbaux, Caroline Bret, Roberta Di Blasi, Emmanuel Bachy, David Beauvais, Elodie Gat, Thomas Gastinne, Florence Broussais, Guillaume Cartron, Alexis Cuffel, Loic Ysebaert, Mikael Roussel, Krimo Bouabdallah, Julien Guy, Arnaud Campidelli, François Van Laethem, Rene-Olivier Casasnovas, Remy Dulery, Franck Morschhauser, Sophie Caillat-Zucman, Roch Houot, Steven Le Gouill
Journal: Blood
Blood (2021) 138 (Supplement 1): 743.
https://doi.org/10.1182/blood-2021-148626
Published: 2021
Journal Articles

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Clinical Trials & Observations
Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron, Arnaud Jaccard, Peter Reimer, Eva Wagner, Martin Wilhelm, Laurence Sanhes, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Muriel Roussel, Frank Kroschinsky, Walter Lindemann, Peter Dreger, Andreas Viardot, Noël Milpied, Christian Gisselbrecht, Gerald Wulf, Emmanuel Gyan, Philippe Gaulard, Jacques Olivier Bay, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Alain Delmer, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac
Journal: Blood
Blood (2021) 137 (19): 2646–2656.
https://doi.org/10.1182/blood.2020008825
Published: 2021
Includes: Supplemental data
Journal Articles

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

Clinical Trials & Observations
Steven Le Gouill, Franck Morschhauser, David Chiron, Krimo Bouabdallah, Guillaume Cartron, Olivier Casasnovas, Caroline Bodet-Milin, Sylviane Ragot, Céline Bossard, Nathalie Nadal, Charles Herbaux, Benoit Tessoulin, Emmanuelle Tchernonog, Cédric Rossi, Rory McCulloch, Thomas Gastinne, Mary B. Callanan, Simon Rule
Journal: Blood
Blood (2021) 137 (7): 877–887.
https://doi.org/10.1182/blood.2020008727
Published: 2021
Includes: Supplemental data
Journal Articles

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Pier Luigi Zinzani, MD, Vladimir Melnichenko, Krimo Bouabdallah, MD, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MDPhD, Dolores Caballero, MD PhD, Beth A. Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Salles, MD PhD, Margaret A. Shipp, MD, Seth Thompson, Robert J Orlowski, MD, Patricia Marinello, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-137080
Published: 2020